PALIVIZUMAB for Pulmonary hypertension: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 71 adverse event reports in the FDA FAERS database where PALIVIZUMAB was used for Pulmonary hypertension.
Most Reported Side Effects for PALIVIZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Respiratory syncytial virus infection | 1,692 | 14.8% | 47 | 1,321 |
| Pyrexia | 1,055 | 9.2% | 25 | 438 |
| Death | 856 | 7.5% | 856 | 94 |
| Bronchiolitis | 724 | 6.3% | 13 | 649 |
| Cough | 665 | 5.8% | 9 | 351 |
| Pneumonia | 657 | 5.8% | 55 | 579 |
| Dyspnoea | 466 | 4.1% | 10 | 370 |
| Nasopharyngitis | 462 | 4.1% | 4 | 206 |
| Vomiting | 445 | 3.9% | 18 | 303 |
| Influenza | 398 | 3.5% | 7 | 261 |
| Product dose omission issue | 381 | 3.3% | 4 | 123 |
| Covid-19 | 360 | 3.2% | 4 | 172 |
| Off label use | 359 | 3.1% | 26 | 166 |
| Illness | 346 | 3.0% | 5 | 103 |
| Nasal congestion | 304 | 2.7% | 3 | 102 |
Other Indications for PALIVIZUMAB
Premature baby (3,353)
Antiviral prophylaxis (3,080)
Product used for unknown indication (1,107)
Respiratory syncytial virus infection (996)
Bronchopulmonary dysplasia (827)
Heart disease congenital (546)
Low birth weight baby (399)
Chronic respiratory disease (206)
Lung disorder (186)
Ventricular septal defect (177)
Other Drugs Used for Pulmonary hypertension
AMBRISENTAN (18,885)
TREPROSTINIL (10,034)
MACITENTAN (5,228)
RIOCIGUAT (3,837)
SILDENAFIL (3,761)
SELEXIPAG (2,500)
EPOPROSTENOL (2,486)
TADALAFIL (2,430)
BOSENTAN (2,337)
ILOPROST (1,123)